Searchable abstracts of presentations at key conferences in endocrinology

ea0052p15 | (1) | UKINETS2017

Platinum-etoposide chemotherapy for extra-pulmonary high grade neuroendocrine carcinoma (EP-G3-NEC): A survey of clinical practice

Lamarca Angela , Frizziero Melissa , Barriuso Jorge , McNamara Mairead G , Hubner Richard A , Valle Juan W

Introduction: Platinum-etoposide chemotherapy is a globally established chemotherapy combination for EP-G3-NEC. However, there are many different schedules for such chemotherapy, and the preferred one for EP-G3-NEC has not been established.Methods: An international survey was created, and completed by colleagues with an expertise in the field of neuroendocrine neoplasms. The aim was to explore which schedules of platinum-etoposide chemotherapy are used a...

ea0085oc10.2 | Oral Communications 10 | BSPED2022

Patient and parent experiences with oral hydrocortisone formulations for adrenal insufficiency

Boulos Nabil , Davis Nikki , Kumaran Anitha , Davies Justin

Background: The choice of hydrocortisone (HC) formulation for children with adrenal insufficiency necessitates considerations for dose accuracy, palatability, and practicality in everyday life to optimise medicine adherence and health outcomes. Recently, several diverse new formulations have become available in the UK, but no information is available on real-life patient preferences for the different formulations.Objectives: Explore patient and parent ex...

ea0089c24 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2022

MIBG and DOTATATE Therapy for Pheochromocytoma and Paraganglioma: A Single Institution Experience

Mittra Erik , Mallak Nadine , Pegna Guillaume , Chen Emerson , Lim James , Pommier Rodney

Background: Since the FDA-approval of Lu177-DOTATATE and I131-MIBG radiopharmaceutical therapies in 2018, there is emerging real-world experience with their use. Only a few institutions in the US have both therapies available. Here, we describe our experience with these agents for patients with pheochromocytoma and paraganglioma (PPGL).Methods: This is a retrospective evaluation of all patients with progressive, metastatic, PPGL referred for radiopharmac...

ea0089c26 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2022

Pre-therapy Functional Imaging with MIBG and DOTATATE to Guide Radiopharmaceutical Therapy for Pheochromocytoma and Paraganglioma: A Single Institution Experience

Mallak Nadine , Szidonya Laszlo , Pegna Guillaume , Pommier Rodney , Mittra Erik

Background: Since their FDA-approval in 2018, both Lu177-DOTATATE and I131-MIBG radiopharmaceutical therapies are available at our institution for the treatment of pheochromocytoma and paraganglioma (PPGL). Tumor uptake of the radiopharmaceutical on pre-therapy imaging is a requirement for treatment. Here, we describe our experience with pre-therapy imaging, and how it relates to the tumor genotype and the therapeutic choice.Methods: This is a retrospect...

ea0038cmw4.5 | Workshop 4: How do I do it? (II) (Supported by <emphasis role="italic">Clinical Endocrinology</emphasis> and <emphasis role="italic">Endocrinology, Diabetes &amp; Metabolism Case Reports</emphasis>) | SFEBES2015

Managing hormone replacement therapy in the learning disabled young adult: a personal practice

Spoudeas Helen

Teenagers and young adult survivors of congenital and acquired brain injury caused by developmental defects (e.g. septooptic dysplasias), brain tumours and their treatment, or intracerebral and systemic disease (e.g. histiocytoses and meningitis), are often both learning disabled and requiring lifesaving (cortisol and desmopressin) and life-enhancing (sex steroid, thyroxine, and growth) hormone replacement due to panhypopituitarism.Managing the parental ...

ea0037ep1040 | Thyroid (non-cancer) | ECE2015

Sensitivity and specificity of thyroid cytology in the diagnosis of malignancy: results of a series of 1567 thyroidectomies

Ma Calderon Dulce , Herraiz Sandra , Sastre Julia , Gonzalez Abel , Fernandez Belen , Valero Miguel Angel , Aguirre Miguel

Introduction: Sensitivity and specificity of thyroid cytology in our series of thyroidectomies were evaluated.Material and methods: A retrospective, multicentre study of 1567 thyroidectomies performed in the eight hospitals of Castilla La Mancha (Spain) during the years 2010–2013.Results: The cytological results were benign in 37.6% of cases, malignant or suspicious of malignancy in 17.3% (10 and 7.3% respectively). In 4.1% of...

ea0037ep1276 | Clinical Cases–Thyroid/Other | ECE2015

Case report: superior vena cava syndrome secondary to intrathoracic goitre

Garcia-Bray Bruno Francisco , Felipe-Perez Nieves Cruz , Darias-Garzon Ricardo , Rivero-Melian Benigno , Llorente-Gomez de Segura Ignacio

Introduction: We introduce a case involving the appearance of superior vena cava syndrome secondary to intrathoracic goitre. We discuss the diagnosis, prognosis and treatment applied to this pathology.Case report: A 67-year-old woman who presents respiratory distress, cough, and weight loss. After physical examination and a chest radiography showing a mass that occupied the upper and middle right lung lobes, a neoplasm is suspected and at first, palliati...

ea0061ou4 | Plenary 1: Can it be healthy to be overweight? Is so when? | OU2019

Can it be healthy to be overweight? If so when?

Kos Katarina

Being overweight or obese is by many people considered a lifestyle choice. It is primarily us healthcare professionals who worry about the health impact of obesity, however are we always right? Whom should we consider at risk and when should we (try) to intervene? Is there something like healthy obesity? This talk is aimed to reflect and understand what happens with adipose tissue when we gain weight, how it copes with surplus energy and how it links with obesity and its compl...

ea0025cm2.3 | Endocrine problems in pregnancy | SFEBES2011

Management of adrenal disorders in pregnancy

Arlt Wiebke

The manifestation of adrenal disorders during pregnancy is a rare but regularly occurring event and can pose significant problems for the involved medical professionals. This lecture will give an overview of the major management issues surrounding disorders of the adrenal cortex during pregnancy. This includes the requirements for the adjustment of corticosteroid replacement therapy in adrenal insufficiency, due to the physiological changes in corticosteroid secretion during p...

ea0008s20 | Consequences of a lack of androgens | SFE2004

Hormonal Male Contraception: An Update

Wu F

Maintenance of spermatogenesis depends on adequate gonadotrophin and intratesticular testosterone concentrations. Hormonal contraception for men interrupts this physiological axis by various means of gonadotrophin suppression; this induces reversible azoospermia or severe oligozoospermia in virtually all men. Clinical trials have confirmed that high contraceptive efficacy, similar to female hormonal contraceptives, can be reliably attained with few side effects. However, the s...